FDA Adverse Event
Malfunction
Summary report: N
ULTEGRA RPFA-TRAP
MDR report key: 285319
·
Received July 7, 2000
Report
- Report Number
- 2031760-2000-00007
- Event Type
- Malfunction
- Date Received
- July 7, 2000
- Date of Event
- June 8, 2000
- Report Date
- July 7, 2000
- Manufacturer
- ACCUMETRICS
- Product Code
- JOZ
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- CA, US
- Reporter Occupation
- NURSE
Narratives
Description of Event or Problem · 1
A BLOOD SAMPLE WAS DRAWN FROM A PT TO OBTAIN A BASELINE (PRE-DRUG) PLATELET FUNCTION TEST RESULT USING THE ULTEGRA RPFA-TRAP. A RESULT OF 239 PAU WAS OBTAINED. NO CP IIB/IIIA INHIBITOR DRUGS WERE ADMINISTERED TO THE PT. FIFTEEN MINUTES AFTER THE FIRST TEST, A SECOND BLOOD SAMPLE WAS OBTAINED AND TESTED. THE ANALYZER REPORTED A RESULT OF 45 PAU, WHICH IS SIGNIFICANTLY LOWER THAN THE BASELINE REFERENCE RANGE CITED IN THE DEVICE PACKAGE INSERT (125-330 PAU).
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | ULTEGRA RPFA-TRAP | PLATELET FUNCTION ASSAY | JOZ | ACCUMETRICS | NA | W03893A |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 81 YR | PLAVIX, OR ANY GP IIB/IIIA INHIBITOR.| THE PT DID NOT RECEIVE ASPIRIN, COUMADIN, HEPARIN, |